Nurse Practitioner and Researcher
Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Dr. Beth Faiman received a bachelor of science in nursing in 1996, a Master of Science in Nursing and certification as an Adult Nurse Practitioner in 2002, and a Ph.D. from Case Western Reserve University in 2014. Dr. Faiman holds an advanced oncology nurse certification through ONCC and was appointed as a Fellow in the American Academy of Nursing, in 2019. She is currently employed as an Adult Nurse Practitioner in the Department of Hematology/Oncology at the Cleveland Clinic in Cleveland, Ohio, and was appointed as a member of Case Comprehensive Cancer Center in 2020. She is the recipient of numerous awards and accolades including the Dean's legacy award for Ph.D. Studies in 2015, and Leukemia/Lymphoma Society Woman of the Year, in 2016.
Dr. Faiman has become an exemplary leader in bringing critical knowledge in cancer nursing to providers- locally, nationally, and internationally. She has established herself as an internationally renowned expert in cancer nursing through research, publications, and presentations; and as a mentor to nurses. Faiman edited the first bone marrow transplant nurse’s certification manual and co-edited the only myeloma nursing textbook. Faiman led the development of international myeloma nurse management guidelines and influenced cancer care practice by presenting at 30 international and 312 US national/regional conferences; including as lecture chair of numerous international and national conferences.
Dr. Faiman remains an active author, presenter, and educator on the topic of plasma cell disorders including amyloidosis. In 2006 she became a founding member of the International Myeloma Foundation Nurse Leadership Board and, in 2019 appointed to the Hematology Specialty Board of the American Board of Internal Medicine. Faiman is currently Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology (JADPRO), founding Editor-in-Chief of The Oncology Nurse APN/PA, and on the editorial board of ASH Clinical News among others.